InVivo Therapeutics Holdings - Stock Price History | NVIV

Historical daily share price chart and data for InVivo Therapeutics Holdings since 2019 adjusted for splits. The latest closing stock price for InVivo Therapeutics Holdings as of October 21, 2019 is 0.49.
  • The all-time high InVivo Therapeutics Holdings stock closing price was 567.00 on July 22, 2013.
  • The InVivo Therapeutics Holdings 52-week high stock price is 2.21, which is 351% above the current share price.
  • The InVivo Therapeutics Holdings 52-week low stock price is 0.40, which is 18.4% below the current share price.
  • The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 1.21.
InVivo Therapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 6.4742 22.7500 22.7500 1.4000 1.5100 -92.16%
2017 62.9060 103.7500 123.7500 19.0000 19.2500 -81.67%
2016 146.4831 181.7500 246.2500 91.5000 105.0000 -41.67%
2015 270.6587 130.0000 444.5000 130.0000 180.0000 36.36%
2014 134.3373 224.0000 260.0000 50.0000 132.0000 -42.61%
2013 263.1389 175.0000 567.0000 110.0000 230.0000 32.18%
2012 212.9680 279.0000 284.0000 128.0000 174.0000 -36.73%
2011 120.9246 196.0000 310.0000 60.0000 275.0000 22.22%
2010 212.5455 250.0000 250.0000 130.0000 225.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.004B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.323B 26.71
Medtronic (MDT) Ireland $145.061B 20.36
Stryker (SYK) United States $80.552B 27.85
Boston Scientific (BSX) United States $53.588B 25.99
Baxter (BAX) United States $44.924B 27.24
EssilorLuxottica Societe Anonyme (ESLOY) France $32.865B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.253B 18.08
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.356B 0.00
Terumo (TRUMY) Japan $24.335B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.897B 0.00
ResMed (RMD) United States $18.864B 35.95
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.229B 54.83
Insulet (PODD) United States $9.266B 549.07
Perrigo (PRGO) Ireland $7.333B 13.51
Canopy Growth (CGC) Canada $7.030B 0.00
Hill-Rom Holdings (HRC) United States $6.817B 20.33
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.648B 0.00
NuVasive (NUVA) United States $3.463B 27.61
Neogen (NEOG) United States $3.393B 56.77
ICU Medical (ICUI) United States $3.219B 20.88
Quidel (QDEL) United States $2.561B 25.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.550B 0.00
Agios Pharmaceuticals (AGIO) United States $1.943B 0.00
National Vision Holdings (EYE) United States $1.805B 38.97
Cardiovascular Systems (CSII) United States $1.730B 0.00
Aphria (APHA) $1.197B 0.00
VAREX IMAGING (VREX) United States $1.103B 25.42
AtriCure (ATRC) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.853B 13.88
Eagle Pharmaceuticals (EGRX) United States $0.843B 21.50
Omeros (OMER) United States $0.782B 0.00
NanoString Technologies (NSTG) United States $0.760B 0.00
Lantheus Holdings (LNTH) United States $0.732B 19.25
LeMaitre Vascular (LMAT) United States $0.696B 41.24
PetIQ (PETQ) United States $0.676B 15.98
Cerus (CERS) United States $0.627B 0.00
Surmodics (SRDX) United States $0.605B 114.95
MacroGenics (MGNX) United States $0.538B 0.00
Quanterix (QTRX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.21
TG Therapeutics (TGTX) United States $0.518B 0.00
Owens & Minor (OMI) United States $0.450B 13.47
Meridian Bioscience (VIVO) United States $0.428B 13.37
Utah Medical Products (UTMD) United States $0.356B 26.11
Zynex (ZYXI) United States $0.340B 36.14
BioLife Solutions (BLFS) United States $0.332B 102.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.326B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.229B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.146B 0.00
Female Health (VERU) United States $0.140B 0.00
Fonar (FONR) United States $0.130B 9.14
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.085B 20.00
Nephros (NEPH) United States $0.083B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00